LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,715
تعداد دریافت فایل اصل مقاله11,291,510
Sayad, Arezou, Akbari, Mohammad Taghi, Mehdizadeh, Mahshid, Taheri, Mohammad, Hajifathali, Abbas. (1393). HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma. سامانه مدیریت نشریات علمی, 11(4), 269-274.
Arezou Sayad; Mohammad Taghi Akbari; Mahshid Mehdizadeh; Mohammad Taheri; Abbas Hajifathali. "HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma". سامانه مدیریت نشریات علمی, 11, 4, 1393, 269-274.
Sayad, Arezou, Akbari, Mohammad Taghi, Mehdizadeh, Mahshid, Taheri, Mohammad, Hajifathali, Abbas. (1393). 'HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma', سامانه مدیریت نشریات علمی, 11(4), pp. 269-274.
Sayad, Arezou, Akbari, Mohammad Taghi, Mehdizadeh, Mahshid, Taheri, Mohammad, Hajifathali, Abbas. HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma. سامانه مدیریت نشریات علمی, 1393; 11(4): 269-274.

HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma

Iranian Journal of Immunology
مقاله 5، دوره 11، شماره 4، اسفند 2014، صفحه 269-274    اصل مقاله (49.21 K)
نوع مقاله: Original Article
نویسندگان
Arezou Sayad1؛ Mohammad Taghi Akbari* 2؛ Mahshid Mehdizadeh3، 4؛ Mohammad Taheri1؛ Abbas Hajifathali* 3
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences
2Department of Medical Genetics, Faculty of Medical Science, Tarbiat Modares University
3Taleghani Bone Marrow Transplantation Center
4Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
چکیده
Background: Non-Hodgkin lymphoma (NHL) includes a wide range of diseases with different clinical and biological features. NHL is usually presented as localized or generalized lymphadenopathy. It has been suggested that the HLA class I and II are associated with susceptibility to NHL. Different ethnic groups have been found to have different HLA class I and II alleles which affect NHL.
Objective: To evaluate the association of HLA class I and class II with Non-Hodgkin’s lymphoma in Iranian patients.
Methods: We performed a case-control genotyping study on 75 Iranian NHL patients who were selected from among the patients referred to the Bone Marrow Transplantation Department of Taleghani Hospital and 120 apparently healthy control subjects using the SSP-PCR by a commercial kit.
Results: Our results demonstrated that the HLA-A*26 (p: 0.026; OR: 8.5) and HLA-B*35 (p: 0.022; OR: 0.375) alleles had positive and negative associations with NHL disease, respectively. HLA-DRB1*13 allele showed decrease of frequency in patients in comparison with the controls, but it did not remain significant after correction.
Conclusions: Our results conclude that HLA-A*26 may represent as a genetic susceptibility factors in Iranian patients with Non-Hodgkin’s lymphoma, a finding which generally supports contribution of genetic factors in the etiology of this disorder. In addition, these results may be useful in designing a peptide based vaccine for the Iranian NHL patients with HLA-A*26.
کلیدواژه‌ها
Genetic Susceptibility؛ HLA-A*26؛ Non Hodgkin Lymphoma
آمار
تعداد مشاهده مقاله: 1,293
تعداد دریافت فایل اصل مقاله: 905


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب